Catalyst Financial Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
VCM
N
Catalyst Financial Partners's REGN Position: Q1 2026 in Review
Catalyst Financial Partners increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q1 2026, buying an estimated $39K and bringing the position to 462 shares worth $357K. The position accounts for 0.04% of the portfolio, ranked #259.
Catalyst Financial Partners first reported a position in REGN in Q3 2023 and has held it in 8 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Catalyst Financial Partners held 462 shares of Regeneron Pharmaceuticals worth $357K as of Q1 2026.
- Catalyst Financial Partners bought 51 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $39K.
- Regeneron Pharmaceuticals made up 0.04% of Catalyst Financial Partners's portfolio in Q1 2026, its #259 holding.
- Catalyst Financial Partners first reported a position in Regeneron Pharmaceuticals in Q3 2023 and has held it in 8 quarters since.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Catalyst Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.